http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2020004838-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bab34457c0c62aadf06ac0280240a61
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 2018-11-02^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_104a75602f95389da2b22d9f3b832657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d6a8c259c57cf723ae58c40af775d35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd2947df8dfabbe625925a07fd7a7422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1295b545e8d58b12ea27b271771e4510
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_901141bc3000220a7071c4f5b720d72f
publicationDate 2020-10-16^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2020004838-A
titleOfInvention NEW INDOL-2-CARBOXAMIDES SUBSTITUTED WITH PYRAZOLOPIPERIDINE, OF HIGH ACTIVITY, ACTIVE AGAINST HEPATITIS B VIRUS (HBV).
abstract The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds that can inhibit the protein(s) encoded by the hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, to compositions comprising these compounds, to methods for inhibiting HBV virus replication, methods for treating or preventing HBV infection, and processes or intermediates for manufacturing the compounds.
priorityDate 2017-11-02^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID594832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420236130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422576911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20784738

Showing number of triples: 1 to 30 of 30.